查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023 年先進 DDS（藥物傳輸系統）全球市場報告
市場調查報告書
商品編碼
1369153

2023 年先進 DDS（藥物傳輸系統）全球市場報告

Advanced Drug Delivery Systems Global Market Report 2023
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球先進DDS（藥物輸送系統）市場預計將從2022年的2,409.7億美元成長到2023年的2,564.3億美元，年複合成長率為6.4%。俄羅斯和烏克蘭之間的戰爭破壞了全球經濟從 COVID-19 大流行中復甦的機會。兩國之間的這場戰爭導致了對多個國家的經濟制裁，大宗商品價格急劇上升，供應鏈中斷，導致商品和服務的通貨膨脹，並導致利率上升，影響了全球許多市場。我就是這麼做的。高級DDS市場預計到2027年將達到3,236.8億美元，年複合成長率為6%。

2022年先進DDS市場的最大地區將是北美。預計亞太地區將成為預測期內成長最快的地區。 Advanced DDS 報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美和中東/非洲。

慢性病患病的增加預計將推動已開發 DDS 市場的未來成長。慢性病是指持續一年以上的問題，需要持續的醫療照護和/或限制日常活動。多種危險行為會導致慢性疾病，包括吸菸、接觸二手菸、營養不良、缺乏運動和過量飲酒。先進的 DDS 能夠將治療藥物輸送到體內受慢性疾病罹患的特定區域。這確保了藥物到達其預期的作用位點，提高其有效性並最大限度地減少副作用。美國美國美國死亡。因此，慢性病患病的增加正在推動已開發 DDS 市場的成長。

目錄

第1章 執行摘要

第2章 先進DDS（藥物傳輸系統）市場的特點

第3章 進階 DDS 市場趨勢與策略

第4章 進階 DDS 市場 - 宏觀經濟情景

  • 高通膨對線上市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章 市場規模與成長

  • 2017-2022 年全球市場規模實績與成長
  • 全球市場規模與成長預測，2022-2027、2032
  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素

第6章 高階 DDS市場區隔

  • 全球先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 口服給藥系統
  • 注射給藥系統
  • 吸入/肺部藥物輸送系統
  • 經皮給藥系統
  • 粘膜給藥系統
  • 基於載體的藥物傳輸系統
  • 其他類型
  • 全球先進 DDS 市場，按營運商類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 脂質體
  • 奈米顆粒
  • 微球
  • 單株抗體
  • 其他營運商類型
  • 全球先進 DDS 市場，按技術細分、實績和預測，2017-2022、2022-2027F、2032F
  • 前藥
  • 植入物和子宮內避孕器
  • 靶向藥物輸送
  • 聚合物藥物遞送
  • 其他技術
  • 全球先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 心血管疾病
  • 腫瘤學
  • 泌尿系統
  • 糖尿病
  • CNS（中樞神經系統）
  • 眼科
  • 發炎疾病
  • 感染疾病
  • 其他用途
  • 全球高級 DDS 市場，按最終用戶細分、實績和預測，2017 年至 2022 年、2022 年至 2027 年、至 2032 年
  • 醫院
  • 專科診所
  • 臨床研發中心

第7章 ：高階 DDS 市場區域與國家分析

  • 全球先進DDS市場，按地區，實績和預測，2017-2022年、2022-2027年、至2032年
  • 全球先進DDS市場，按國家、實績和預測，2017-2022年、2022-2027年、至2032年

第8章 亞太地區先進DDS市場

  • 亞太地區高級 DDS 市場概覽
  • 區域資訊、COVID-19疾病的影響、市場資訊、背景資訊、政府配合措施、法規、法規機構、主要組織、課稅、企業稅務結構、投資、主要企業
  • 亞太地區高級 DDS 市場，按類型細分、實績和預測，2017-2022 年、2022-2027 年、2032 年
  • 亞太地區高級 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 亞太地區高級 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第9章 中國先進DDS市場

  • 中國先進DDS市場概況
  • 中國先進DDS市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 中國先進DDS市場，依用途細分、實績與預測，2017-2022、2022-2027F、2032F
  • 中國先進DDS市場，依最終用戶細分，實績與預測，2017-2022、2022-2027F、2032F

第10章 印度先進的DDS市場

  • 印度先進 DDS 市場，按類型細分、實績和預測，2017-2022 年、2022-2027 年、2032 年
  • 印度先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 印度先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第11章日本先進的DDS市場

  • 日本先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 日本先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 日本先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第12章澳洲先進的DDS市場

  • 澳洲高級 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 澳洲先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 澳洲先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第13章印尼先進的DDS市場

  • 印尼高級 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 印尼先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 印尼高級 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第14章韓國先進的DDS市場

  • 韓國先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 韓國先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 韓國先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第15章西歐先進DDS市場

  • 西歐先進DDS市場概況
  • 西歐先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 西歐先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 西歐先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第16章英國先進DDS市場

  • 英國先進 DDS 市場，按類型、實績和預測細分，2017-2022、2022-2027F、2032F
  • 英國先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 英國先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第17章德國先進的DDS市場

  • 德國先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 德國先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 德國先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第18章法國先進的DDS市場

  • 法國先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 法國先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 法國先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第19章義大利先進的DDS市場

  • 義大利先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 義大利先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 義大利先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第20章西班牙先進的DDS市場

  • 西班牙先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 西班牙先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 西班牙先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第21章東歐先進DDS市場

  • 東歐先進DDS市場概況
  • 東歐先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 東歐先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 東歐先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第22章俄羅斯先進的DDS市場

  • 俄羅斯先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 俄羅斯先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 俄羅斯先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第23章北美先進DDS市場

  • 北美先進DDS市場概況
  • 北美高級 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 北美高級 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 北美高級 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第24章美國先進DDS市場

  • 美國先進DDS市場概況
  • 美國先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 美國先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 美國先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第25章加拿大先進的DDS市場

  • 加拿大先進的DDS市場概況
  • 加拿大先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 加拿大先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 加拿大先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第26章南美洲先進的DDS市場

  • 南美洲先進DDS市場概況
  • 南美洲高級 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 南美洲先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 南美高級 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第27章巴西先進的DDS市場

  • 巴西高級 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 巴西先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 巴西高級 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第28章中東先進DDS市場

  • 中東先進DDS市場概況
  • 中東先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 中東先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 中東先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第29章非洲先進的DDS市場

  • 非洲先進DDS市場概況
  • 非洲先進 DDS 市場，按類型細分、實績和預測，2017-2022、2022-2027F、2032F
  • 非洲先進 DDS 市場，按用途細分、實績和預測，2017-2022、2022-2027F、2032F
  • 非洲先進 DDS 市場，按最終用戶細分，實績和預測，2017-2022、2022-2027F、2032F

第30章先進DDS市場競爭形勢及公司概況

  • 先進DDS市場的競爭形勢
  • 先進DDS市場公司概況
    • Pfizer Inc.
    • Johnson and Johnson Services Inc.
    • Roche Holding AG
    • AbbVie Inc.
    • Bayer AG

第31章先進DDS市場的其他主要和創新公司

  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • 3M Company
  • Medtronic plc
  • Eli Lilly and Company
  • Boehringer Ingelheim GmbH
  • Amgen Inc.
  • Merck Group
  • Becton Dickinson and Company
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA

第32章全球先進DDS市場競爭基準化分析

第33章全球先進DDS市場競爭儀錶板

第34章高級DDS市場的重大併購

第35章先進DDS市場未來前景及潛力分析

  • 2027 年的市場 - 提供最新機會的國家
  • 2027 年的市場 - 提供最新機會的細分市場
  • 2027 年市場 - 成長策略
  • 基於市場趨勢的策略
  • 競爭策略

第36章附錄

簡介目錄
Product Code: r8632

“Advanced Drug Delivery Systems Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The advanced drug delivery systems market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System; Other Types
  • 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
  • 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
  • 4) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; CNS (Central Nervous System); Ophthalmology; Inflammatory Diseases; Infections; Other Applications
  • 5) By End User: Hospitals; Specialized clinics; Clinical Research And Development Centers
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; Abbvie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Italy; Spain; Canada
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the advanced drug delivery systems market are: Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, F. Hoffmann-La Roche Ltd., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, and Insulet Corporation.

The global advanced drug delivery systems market is expected to grow from $240.97 billion in 2022 to $256.43 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The advanced drug delivery systems market is expected to reach $323.68 billion in 2027 at a CAGR of 6%.

The advanced drug delivery systems market consists of revenues earned by entities by providing stimuli-responsive drug delivery systems, sustained drug delivery systems, targeted drug delivery systems, and nanoparticle-based drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced drug delivery systems market also consists of sales of fentanyl transdermal patches, albuterol inhalers, and hydrogels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Advanced drug delivery systems refer to innovative techniques and formulations that improve pharmaceutical medications' targeted distribution, bioavailability, and efficacy. These systems maximize drug efficacy and minimize side effects, control the drug release rate, and target specific body areas.

North America was the largest region in the advanced drug delivery systems market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in advanced drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of advanced drug delivery systems are oral drug delivery systems, injection-based drug delivery systems, inhalation or pulmonary drug delivery system, transdermal drug delivery system, transmucosal drug delivery system, carrier-based drug delivery systems, and others. The oral drug delivery system refers to the process of introducing a chemical through the mouth or into the gastrointestinal tract, typically for systemic activity. The carrier types are liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. It employs technology such as prodrugs, implants, intrauterine devices, targeted drug delivery, polymeric drug delivery, and others. These delivery systems are used for indicate cardiovascular diseases, oncology, urology, diabetes, CNS (central nervous system), ophthalmology, inflammatory diseases, infections, and others, which are used by hospitals, specialized clinics, clinical research and development centers.

The increasing prevalence of chronic conditions is expected to propel the growth of the advanced drug delivery systems market going forward. Chronic conditions are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Various risk behaviors, including tobacco use and exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use, cause chronic diseases. Advanced drug delivery systems allow targeted delivery of therapeutic agents to specific sites in the body affected by chronic conditions. They ensure the drug reaches the intended site of action, increasing its effectiveness and minimizing side effects. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases are responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans each year. Therefore, the increasing prevalence of chronic conditions is driving the growth of the advanced drug delivery systems market.

Advancements in technology are a key trend gaining popularity in the advanced drug delivery systems market. Major companies operating in the advanced drug delivery systems market are adopting new technologies to sustain their position in the market. For instance, in June 2023, Shilpa Medicare Limited, an India-based manufacturer and supplier of API and formulation, launched Molshil, the world's first oral thin film formulation of a pediatric dose of paracetamol. The new paracetamol formulation will have the benefits of being extremely palatable and easy to administer while also doing away with some of the disadvantages of the pediatric formulations.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed amount. With this acquisition, Halozyme will enhance its strategy, solidify its top drug delivery firm position, and expand its approach to covering specialized goods with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical firm that creates and markets custom-designed drug delivery medications by combining drug development expertise with proprietary delivery technology to deliver safe and effective medicines.

The countries covered in the advanced drug delivery systems market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The advanced drug delivery systems research report is one of a series of new reports from The Business Research Company that provides advanced drug delivery systems market statistics, including the advanced drug delivery systems industry's global market size, regional shares, competitors with advanced drug delivery systems market share, detailed advanced drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the advanced drug delivery systems industry. This advanced drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Advanced Drug Delivery Systems Market Characteristics

3. Advanced Drug Delivery Systems Market Trends And Strategies

4. Advanced Drug Delivery Systems Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On Online Therapy Services Market
  • 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
  • 4.3. COVID-19 Impact On Online Therapy Services Market
  • 5.1. Global Advanced Drug Delivery Systems Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Advanced Drug Delivery Systems Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
  • 5.3. Global Advanced Drug Delivery Systems Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)

6. Advanced Drug Delivery Systems Market Segmentation

  • 6.1. Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral Drug Delivery System
  • Injection-Based Drug Delivery System
  • Inhalation/Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Transmucosal Drug Delivery System
  • Carrier-Based Drug Delivery System
  • Other Types
  • 6.2. Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Liposomes
  • Nanoparticles
  • Microspheres
  • Monoclonal Antibodies
  • Other Carrier Types
  • 6.3. Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Prodrug
  • Implants And Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Other Technologies
  • 6.4. Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • CNS (Central Nervous System)
  • Ophthalmology
  • Inflammatory Diseases
  • Infections
  • Other Applications
  • 6.5. Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Specialized clinics
  • Clinical Research And Development Centers

7. Advanced Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Advanced Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Advanced Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Advanced Drug Delivery Systems Market

  • 8.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.4. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Advanced Drug Delivery Systems Market

  • 9.1. China Advanced Drug Delivery Systems Market Overview
  • 9.2. China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.4. China Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Advanced Drug Delivery Systems Market

  • 10.1. India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.3. India Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Advanced Drug Delivery Systems Market

  • 11.1. Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.3. Japan Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Advanced Drug Delivery Systems Market

  • 12.1. Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.3. Australia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Advanced Drug Delivery Systems Market

  • 13.1. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.3. Indonesia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Advanced Drug Delivery Systems Market

  • 14.1. South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.3. South Korea Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Advanced Drug Delivery Systems Market

  • 15.1. Western Europe Advanced Drug Delivery Systems Market Overview
  • 15.2. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.4. Western Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Advanced Drug Delivery Systems Market

  • 16.1. UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.3. UK Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Advanced Drug Delivery Systems Market

  • 17.1. Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.3. Germany Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Advanced Drug Delivery Systems Market

  • 18.1. France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.3. France Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Italy Advanced Drug Delivery Systems Market

  • 19.1. Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.2. Italy Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Italy Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Spain Advanced Drug Delivery Systems Market

  • 20.1. Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Spain Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.3. Spain Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. Eastern Europe Advanced Drug Delivery Systems Market

  • 21.1. Eastern Europe Advanced Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.4. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. Russia Advanced Drug Delivery Systems Market

  • 22.1. Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.2. Russia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. Russia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. North America Advanced Drug Delivery Systems Market

  • 23.1. North America Advanced Drug Delivery Systems Market Overview
  • 23.2. North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. North America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.4. North America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. USA Advanced Drug Delivery Systems Market

  • 24.1. USA Advanced Drug Delivery Systems Market Overview
  • 24.2. USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.3. USA Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.4. USA Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Canada Advanced Drug Delivery Systems Market

  • 25.1. Canada Advanced Drug Delivery Systems Market Overview
  • 25.2. Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Canada Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.4. Canada Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. South America Advanced Drug Delivery Systems Market

  • 26.1. South America Advanced Drug Delivery Systems Market Overview
  • 26.2. South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. South America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.4. South America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Brazil Advanced Drug Delivery Systems Market

  • 27.1. Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 27.2. Brazil Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 27.3. Brazil Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

28. Middle East Advanced Drug Delivery Systems Market

  • 28.1. Middle East Advanced Drug Delivery Systems Market Overview
  • 28.2. Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 28.3. Middle East Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 28.4. Middle East Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

29. Africa Advanced Drug Delivery Systems Market

  • 29.1. Africa Advanced Drug Delivery Systems Market Overview
  • 29.2. Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 29.3. Africa Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 29.4. Africa Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

30. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Advanced Drug Delivery Systems Market Competitive Landscape
  • 30.2. Advanced Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Advanced Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. F. Hoffmann-La Roche Ltd.
  • 31.3. AstraZeneca plc
  • 31.4. Abbott Laboratories
  • 31.5. GlaxoSmithKline plc
  • 31.6. 3M Company
  • 31.7. Medtronic plc
  • 31.8. Eli Lilly and Company
  • 31.9. Boehringer Ingelheim GmbH
  • 31.10. Amgen Inc.
  • 31.11. Merck Group
  • 31.12. Becton Dickinson and Company
  • 31.13. Baxter International Inc.
  • 31.14. Teva Pharmaceutical Industries Ltd.
  • 31.15. Sanofi S.A.

32. Global Advanced Drug Delivery Systems Market Competitive Benchmarking

33. Global Advanced Drug Delivery Systems Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Advanced Drug Delivery Systems Market

35. Advanced Drug Delivery Systems Market Future Outlook and Potential Analysis

  • 35.1 Advanced Drug Delivery Systems Market In 2027 - Countries Offering Most New Opportunities
  • 35.2 Advanced Drug Delivery Systems Market In 2027 - Segments Offering Most New Opportunities
  • 35.3 Advanced Drug Delivery Systems Market In 2027 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer